Nurse Practitioner Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Hazel Smith

Clinical Nurse Specialist, Psychiatric/Mental Health Shreveport, LA Nurse Practitioner

NPI 1629081872 CMS profile 10421575

510 E Stoner Ave, Shreveport, LA 71101

Open in the dashboard

General payments

$1,944

78 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Hazel Smith of Shreveport, LA is reported in the CMS Open Payments database as having received $1,944 across 78 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 74th percentile of Clinical Nurse Specialist, Psychiatric/Mental Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $227 7
2023 General $239 13
2022 General $792 21
2021 General $685 37

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hazel Smith
  • Clinical Nurse Specialist, Psychiatric/Mental Health median
  • Middle half of Clinical Nurse Specialist, Psychiatric/Mental Health
  • National median

In program year 2025, general payments to Hazel Smith were reported at $0. Among 300 Clinical Nurse Specialist, Psychiatric/Mental Health profiles paid that year, the median was $245 and the middle half received between $78 and $929.

Show as a table
Year Hazel Smith Clinical Nurse Specialist, Psychiatric/Mental Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $685 $153 $44–$540 $132
2022 $792 $207 $60–$748 $149
2023 $239 $197 $55–$898 $160
2024 $227 $189 $49–$804 $164
2025 $0 $245 $78–$929 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. Neurocrine Biosciences, Inc. $483 17 payments
  2. Teva Pharmaceuticals USA, Inc. $442 19 payments
  3. Alkermes, Inc. $384 13 payments
  4. Janssen Pharmaceuticals, Inc $172 9 payments
  5. ITI, Inc. $161 8 payments
  6. AbbVie, Inc. $125 1 payment
  7. Lundbeck LLC $73 5 payments
  8. Otsuka America Pharmaceutical, Inc. $67 3 payments
  9. Sunovion Pharmaceuticals Inc. $19 2 payments
  10. E.R. Squibb & Sons, L.L.C. $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Food and Beverage $1,897 77 payments
  2. Education $47 1 payment
Products named General payments · program years 2021–2024
  1. AUSTEDO $381 16 payments
  2. ARISTADA Cns $337 12 payments
  3. ARISTADA Cns $337 12 payments
  4. ARISTADA INITIO $306 10 payments
  5. ARISTADA Cns $272 8 payments
  6. ARISTADA Cns $272 8 payments
  7. INGREZZA Neuropsychiatry $271 7 payments
  8. INGREZZA Neurology $211 10 payments
  9. INVEGA SUSTENNA $172 9 payments
  10. CAPLYTA $161 8 payments
  11. Other $824 35 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

78 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Nurse Specialist, Psychiatric/Mental Health in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record